{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:40:03Z","timestamp":1792813203211,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s12253-015-9897-8","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T07:43:04Z","timestamp":1424331784000},"page":"821-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides"],"prefix":"10.1007","volume":"21","author":[{"given":"D\u00f3ra","family":"Marosv\u00e1ri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"T\u00e9gl\u00e1si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e9n","family":"Csala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Marschalk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"B\u00f6d\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond","family":"Tim\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Csomor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"H\u00e1rsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Reiniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"9897_CR1","unstructured":"Swerdlow SH, International Agency for Research on Cancer., World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer, 2008"},{"key":"9897_CR2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u201385","journal-title":"Blood"},{"key":"9897_CR3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","volume":"170","author":"JJ Scarisbrick","year":"2014","unstructured":"Scarisbrick JJ, Kim YH, Whittaker SJ et al (2014) Prognostic factors, prognostic indices and staging in mycosis fungoides and sezary syndrome: where are we now? Br J Dermatol 170:1226\u201336","journal-title":"Br J Dermatol"},{"key":"9897_CR4","first-page":"738","volume":"144","author":"P Gerami","year":"2008","unstructured":"Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J (2008) Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol 144:738\u201346","journal-title":"Arch Dermatol"},{"key":"9897_CR5","first-page":"2212","volume":"95","author":"B Vergier","year":"2000","unstructured":"Vergier B, de Muret A, Beylot-Barry M et al (2000) Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases french study group of cutaneious lymphomas. Blood 95:2212\u20138","journal-title":"Blood"},{"key":"9897_CR6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","volume":"119","author":"MF Benner","year":"2012","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R (2012) Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood 119:1643\u20139","journal-title":"Blood"},{"key":"9897_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","volume":"155","author":"HK Wong","year":"2011","unstructured":"Wong HK, Mishra A, Hake T, Porcu P (2011) Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol 155:150\u201366","journal-title":"Br J Haematol"},{"key":"9897_CR8","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","volume":"23","author":"R Doorn van","year":"2005","unstructured":"van Doorn R, Zoutman WH, Dijkman R et al (2005) Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 23:3886\u201396","journal-title":"J Clin Oncol"},{"key":"9897_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOH.0b013e328303e15d","volume":"15","author":"R Garzon","year":"2008","unstructured":"Garzon R, Croce CM (2008) MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15:352\u20138","journal-title":"Curr Opin Hematol"},{"key":"9897_CR10","doi-asserted-by":"crossref","first-page":"17085","DOI":"10.3390\/ijms140817085","volume":"14","author":"F Calore","year":"2013","unstructured":"Calore F, Lovat F, Garofalo M (2013) Non-coding RNAs and cancer. Int J Mol Sci 14:17085\u2013110","journal-title":"Int J Mol Sci"},{"key":"9897_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","volume":"5","author":"MS Kester van","year":"2011","unstructured":"van Kester MS, Ballabio E, Benner MF et al (2011) miRNA expression profiling of mycosis fungoides. Mol Oncol 5:273\u201380","journal-title":"Mol Oncol"},{"key":"9897_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2011.10669.x","volume":"166","author":"J Maj","year":"2011","unstructured":"Maj J, Jankowska-Konsur A, Sadakierska-Chudy A, Noga L, Reich A (2011) Altered microRNA expression in mycosis fungoides. Br J Dermatol 166:331\u20136","journal-title":"Br J Dermatol"},{"key":"9897_CR13","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","volume":"118","author":"U Ralfkiaer","year":"2011","unstructured":"Ralfkiaer U, Hagedorn PH, Bangsgaard N et al (2011) Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 118:5891\u2013900","journal-title":"Blood"},{"key":"9897_CR14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/exd.12161","volume":"22","author":"L Moyal","year":"2013","unstructured":"Moyal L, Barzilai A, Gorovitz B et al (2013) miR-155 is involved in tumor progression of mycosis fungoides. Exp Dermatol 22:431\u20133","journal-title":"Exp Dermatol"},{"key":"9897_CR15","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2007-08-109074","volume":"111","author":"E Contassot","year":"2008","unstructured":"Contassot E, Kerl K, Roques S et al (2008) Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression. Blood 111:4780\u20137","journal-title":"Blood"},{"key":"9897_CR16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","volume":"118","author":"O Dereure","year":"2002","unstructured":"Dereure O, Levi E, Vonderheid EC, Kadin ME (2002) Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 118:949\u201356","journal-title":"J Invest Dermatol"},{"key":"9897_CR17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","volume":"129","author":"J Wu","year":"2009","unstructured":"Wu J, Nihal M, Siddiqui J, Vonderheid EC, Wood GS (2009) Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation. J Invest Dermatol 129:1165\u201373","journal-title":"J Invest Dermatol"},{"key":"9897_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.leu.2401415","volume":"13","author":"M Nielsen","year":"1999","unstructured":"Nielsen M, Kaestel CG, Eriksen KW et al (1999) Inhibition of constitutively activated Stat3 correlates with altered Bcl-2\/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13:735\u20138","journal-title":"Leukemia"},{"key":"9897_CR19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","volume":"18","author":"VH Sommer","year":"2004","unstructured":"Sommer VH, Clemmensen OJ, Nielsen O et al (2004) In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia 18:1288\u201395","journal-title":"Leukemia"},{"key":"9897_CR20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2133.2004.06106.x","volume":"151","author":"X Mao","year":"2004","unstructured":"Mao X, Orchard G, Lillington DM et al (2004) BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 151:546\u201356","journal-title":"Br J Dermatol"},{"key":"9897_CR21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","volume":"35","author":"X Mao","year":"2008","unstructured":"Mao X, Orchard G, Mitchell TJ et al (2008) A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. J Cutan Pathol 35:899\u2013910","journal-title":"J Cutan Pathol"},{"key":"9897_CR22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2133.2002.04966.x","volume":"147","author":"X Mao","year":"2002","unstructured":"Mao X, Lillington D, Scarisbrick JJ et al (2002) Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in sezary syndrome and mycosis fungoides. Br J Dermatol 147:464\u201375","journal-title":"Br J Dermatol"},{"key":"9897_CR23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1600-0625.2012.01548.x","volume":"21","author":"MF Benner","year":"2012","unstructured":"Benner MF, Ballabio E, van Kester MS et al (2012) Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides. Exp Dermatol 21:632\u20134","journal-title":"Exp Dermatol"},{"key":"9897_CR24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/gcc.20469","volume":"46","author":"M Prochazkova","year":"2007","unstructured":"Prochazkova M, Chevret E, Mainhaguiet G et al (2007) Common chromosomal abnormalities in mycosis fungoides transformation. Genes, Chromosom Cancer 46:828\u201338","journal-title":"Genes, Chromosom Cancer"},{"key":"9897_CR25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.196","volume":"23","author":"E Laharanne","year":"2010","unstructured":"Laharanne E, Chevret E, Idrissi Y et al (2010) CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. Mod Pathol 23:547\u201358","journal-title":"Mod Pathol"},{"key":"9897_CR26","doi-asserted-by":"crossref","first-page":"e29541","DOI":"10.1371\/journal.pone.0029541","volume":"7","author":"V Manfe","year":"2012","unstructured":"Manfe V, Biskup E, Rosbjerg A et al (2012) miR-122 regulates p53\/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 7:e29541","journal-title":"PLoS One"},{"key":"9897_CR27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/jid.2013.461","volume":"134","author":"LY McGirt","year":"2013","unstructured":"McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM (2013) miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides\/cutaneous T-cell lymphoma. J Investi Dermatol 134:1101\u20137","journal-title":"J Investi Dermatol"},{"key":"9897_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biocel.2012.11.004","volume":"45","author":"QS Mi","year":"2013","unstructured":"Mi QS, Xu YP, Wang H, Qi RQ, Dong Z, Zhou L (2013) Deletion of microRNA miR-223 increases Langerhans cell cross-presentation. Int J Biochem Cell Biol 45:395\u2013400","journal-title":"Int J Biochem Cell Biol"},{"key":"9897_CR29","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/onc.2010.634","volume":"30","author":"E Sotillo","year":"2011","unstructured":"Sotillo E, Laver T, Mellert H et al (2011) Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 30:2587\u201394","journal-title":"Oncogene"},{"key":"9897_CR30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/nat.2012.0343","volume":"22","author":"M Rizzo","year":"2012","unstructured":"Rizzo M, Mariani L, Cavallini S, Simili M, Rainaldi G (2012) The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation. Nucleic acid therapeutics 22:283\u20138","journal-title":"Nucleic acid therapeutics"},{"key":"9897_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0344-0338(11)80423-1","volume":"190","author":"P Kanavaros","year":"1994","unstructured":"Kanavaros P, Ioannidou D, Tzardi M et al (1994) Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 190:767\u201374","journal-title":"Pathol Res Pract"},{"key":"9897_CR32","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","volume":"130","author":"R Salgado","year":"2010","unstructured":"Salgado R, Servitje O, Gallardo F et al (2010) Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J invest Dermatol 130:1126\u201335","journal-title":"J invest Dermatol"},{"key":"9897_CR33","first-page":"4352","volume":"11","author":"L Fang","year":"2012","unstructured":"Fang L, Du WW, Yang W et al (2012) MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell cycle (Georgetown. Tex 11:4352\u201365","journal-title":"Tex"},{"key":"9897_CR34","first-page":"113","volume":"2","author":"Y Xi","year":"2006","unstructured":"Xi Y, Formentini A, Chien M et al (2006) Prognostic values of microRNAs in colorectal cancer. Biomark Insights 2:113\u201321","journal-title":"Biomark Insights"},{"key":"9897_CR35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1947601910366860","volume":"1","author":"G Mansueto","year":"2010","unstructured":"Mansueto G, Forzati F, Ferraro A et al (2010) Identification of a New pathway for tumor progression: MicroRNA-181b Up-regulation and CBX7 down-regulation by HMGA1 protein. Genes & cancer 1:210\u201324","journal-title":"Genes & cancer"},{"key":"9897_CR36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI64946","volume":"123","author":"MA Taylor","year":"2013","unstructured":"Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, Schiemann WP (2013) TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest 123:150\u201363","journal-title":"J Clin Invest"},{"key":"9897_CR37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/onc.2010.465","volume":"30","author":"L Fang","year":"2010","unstructured":"Fang L, Deng Z, Shatseva T et al (2010) MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 30:806\u201321","journal-title":"Oncogene"},{"key":"9897_CR38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1101\/sqb.2013.78.020024","volume":"78","author":"A Williams","year":"2013","unstructured":"Williams A, Henao-Mejia J, Harman CC, Flavell RA (2013) miR-181 and metabolic regulation in the immune system. Cold Spring Harb Symp Quant Biol 78:223\u201330","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"9897_CR39","doi-asserted-by":"crossref","first-page":"D78","DOI":"10.1093\/nar\/gkt1266","volume":"42","author":"SD Hsu","year":"2014","unstructured":"Hsu SD, Tseng YT, Shrestha S et al (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 42:D78\u201385","journal-title":"Nucleic Acids Res"},{"key":"9897_CR40","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V95.9.2937.009k15_2937_2942","volume":"95","author":"JJ Scarisbrick","year":"2000","unstructured":"Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ (2000) Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95:2937\u201342","journal-title":"Blood"},{"key":"9897_CR41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/DAD.0b013e318276cc68","volume":"35","author":"TM Katona","year":"2013","unstructured":"Katona TM, Smoller BR, Webb AL, Hattab EM, Khalil A, Hiatt KM (2013) Expression of PTEN in mycosis fungoides and correlation with loss of heterozygosity. Am J Dermatopathol 35:555\u201360","journal-title":"Am J Dermatopathol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-015-9897-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-015-9897-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-015-9897-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T04:23:30Z","timestamp":1598761410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-015-9897-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["9897"],"URL":"https:\/\/doi.org\/10.1007\/s12253-015-9897-8","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}